Research Gone Right!

See what some of our researchers have uncovered through precision protocols and consistent quality. From dramatic body composition changes to optimized metabolic markers, our peptides are fueling some of the most promising findings in today’s weight loss and longevity studies.

⚠️ Disclaimer: The information provided is for educational and research purposes only. These compounds are not approved for human use, and we do not promote or suggest the use of any peptides for self-administration, therapeutic treatment, or consumption. All products are strictly intended for qualified laboratory research.

View more

Key Research Applications & Benefits

Free shipping & Satisfaction Guarantee

Key Biological Pathways Activated

Studies

NEJM Study: Triple Agonists and Obesity Reduction

Source: Jastreboff et al., New England Journal of Medicine, 2023

  • Summary: This Phase 2 clinical trial demonstrated significant weight loss in participants administered Retatrutide, showing greater reductions in body fat percentage than GLP-1-only therapies like semaglutide.
  • Findings: Average weight reduction of up to 24% at higher doses.
  • Official URL
Nature Metabolism: Retatrutide in Rodent & Primate Models

Source: Killion et al., Nature Metabolism, 2022

  • Summary: This preclinical study evaluated Retatrutide’s effect on metabolic rate and thermogenesis. Results confirmed multi-receptor activation (GLP-1/GIP/GCGR) increases fat oxidation and improves insulin sensitivity.
  • Findings: Enhanced basal metabolism and lower adiposity in rodent subjects.
  • Official URL
FDA Investigational Drug Pipeline (IND Reports)

Source: U.S. Food & Drug Administration, 2023

  • Summary: Retatrutide is listed as an active candidate in the FDA’s investigational pipeline for obesity and metabolic disorder research. Clinical monitoring is ongoing as part of GLP-1/GIP/GCGR combination trials.
  • Details: Legal classification: Investigational. Not approved for medical use.
  • Official URL
Endocrinology Today: Hormonal Balance & Glucose Control

Source: Hall et al., Endocrinology Today, 2022

  • Summary: The article covers endocrine modulation through triple agonists like Retatrutide and their impact on beta-cell function and energy stability in lab models.
  • Findings: Improved glucose regulation and reduced fasting insulin levels.
  • Official URL

FAQs

Please read our FAQs page to find out more.

What is the recommended Retatrutide dosage in research studies?

Retatrutide dosing in research models typically starts at 0.25mg, with gradual titration up to 0.5mg or 1mg based on the subject and study goals. Many researchers follow weekly escalation protocols to evaluate metabolic response and peptide tolerance over time.

Is Retatrutide a natural peptide?

No, Retatrutide is a synthetic tri-agonist peptide. It is engineered to mimic and enhance the action of natural hormones such as GLP-1GIP, and glucagon for advanced metabolic research. It is not naturally occurring, but designed to target endogenous hormone receptors with precision.

Can Retatrutide be combined with Tesamorelin in a research stack?

Yes, Retatrutide and Tesamorelin are commonly stacked in research for enhanced fat loss and metabolic performance. This combination is studied for its synergistic impact on growth hormone releaselipolysis, and body composition improvement.

What’s the best way to reconstitute Retatrutide?

Retatrutide should be reconstituted using Sterile Water for Injection (SWFI) or Bacteriostatic Water (BAC). Both are considered acceptable for laboratory use. Follow your lab’s standard operating procedures (SOPs) and ensure sterile technique is maintained during reconstitution.

How does Retatrutide compare to Semaglutide in research?

Research suggestsRetatrutide outperforms Semaglutidein several metabolic markers. Due to itstriple-receptor mechanism(GLP-1, GIP, and GCGR), Retatrutide shows greater efficacy infat loss,insulin regulation, andenergy expenditurecompared to single-pathway peptides like Semaglutide.

Didn’t find your answer?

Don't hestitate to contact us